Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Más información
Título de la Revista: | Journal of the American Heart Association |
Volumen: | 4 |
Asunto: | 12 |
Fecha de publicación: | 2015 |
DOI/URL: |
10.1161/JAHA.115.002015 |